Initial results of efficacy and safety of sofosbuvir among Pakistani population: a real life trialhepatitis eradication accuracy trial of sofosbuvir [HEATS]
Pakistan Journal of Medical Sciences. 2017; 33 (1): 48-52
en Inglés
| IMEMR
| ID: emr-185476
ABSTRACT
Objective:
The uridine nucleotide analogue sofosbuvir is a selective inhibitor of hepatitis C virus [HCV] NS5B polymerase approved for the treatment of chronic HCV infection with genotypes 1 - 4. The objective of the study was to evaluate the interim results of efficacy and safety of regimens containing Sofosbuvir [Zoval] among Pakistani population with the rapid virologic response [RVR2/4 weeks] with HCV infections
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Pak. J. Med. Sci.
Año:
2017
Similares
MEDLINE
...
LILACS
LIS